Generic Versions of ADHD Drug Vyvanse Approved by FDA

The Food and Drug Administration (FDA) has granted approval for the first generic versions of Vyvanse, a medication used to treat attention deficit/hyperactivity disorder (ADHD). This decision comes at a critical time when there is a shortage of ADHD treatment drugs across the country. According to the FDA’s announcement, the newly approved generic medication is …

Read more

FDA Announces Significant Updates in Postpartum Depression Research and Treatment

Every year, hundreds of thousands of women experience postpartum depression, a serious condition that can persist for months or even years after childbirth. For some women, these feelings can become dangerous. However, there is hope on the horizon. The Food and Drug Administration (FDA) has approved a groundbreaking new pill, Zurzuvae, specifically designed to …

Read more

National: FDA Grants Approval for First Postpartum Depression Pill in U.S.

Federal health officials have given their approval for the first pill specifically designed to treat severe depression after childbirth. This groundbreaking medication, called Zurzuvae, offers new hope for the thousands of new mothers in the United States who experience this condition each year. Zurzuvae, developed by Sage Therapeutics, is taken orally once a day for …

Read more

First Oral Treatment for Postpartum Depression Receives FDA Approval

August 4, 2023 (UPI) — The Food and Drug Administration (FDA) has granted approval for a groundbreaking hormone-based medication aimed at treating postpartum depression, a condition that affects approximately 1 in 8 new mothers. The newly approved medication, known as zuranolone, will be marketed under the brand name Zurzuvae. It is the first oral treatment …

Read more

FDA Warns Tydemy Birth Control Pills Recalled Due to Possible Ineffectiveness

Thousands of Tydemy brand birth control pills are being recalled by the Food and Drug Administration (FDA) after testing by drugmaker Lupin Pharmaceuticals revealed potential reduced effectiveness in two specific lots. The recalled batches of Tydemy pills, which are a combination prescription contraceptive, are listed on the FDA’s website and were distributed nationwide from June …

Read more

Opill Becomes First Over-the-Counter Birth Control Pill Approved by FDA

The U.S. Food and Drug Administration has given the green light to the first over-the-counter birth control pill, marking a significant milestone in reproductive health. The pill, known as Opill, is manufactured by Perrigo and offers an alternative for individuals seeking oral contraceptives without a prescription. This decision aims to address the barriers to access …

Read more

WHO: Aspartame, an Artificial Sweetener, Potentially Carcinogenic

A recent statement from the World Health Organization (WHO) suggests that the artificial sweetener aspartame, commonly found in diet beverages, may be carcinogenic for humans. According to the WHO’s International Agency for Research on Cancer and Joint Expert Committee on Food Additives, further studies are needed to investigate this potential health risk. While evidence linking …

Read more

Controversy Emerges within WHO Groups: Aspartame’s Possible Link to Cancer Raises Concerns, but Deemed Safe for Consumption

New Research Links Aspartame to Cancer, While Others Assert Its Safety New findings from the International Agency for Research on Cancer (IARC), a branch of the World Health Organization (WHO), suggest that the artificial sweetener aspartame may be carcinogenic. However, the Joint Expert Committee on Food Additives (JECFA), another WHO-affiliated group, maintains that aspartame is …

Read more